Alternative views on the effects of recombinant interleukin-1-receptor antagonist.
Vance-Bryan
K
K
Hoey
L L
LL
Joslin
S M
SM
D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012772:Shock, Septic / Q000628:therapy; D012795:Sialoglycoproteins / Q000009:adverse effects* / Q000627:therapeutic use
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins